Exact Sciences (EXAS) Tops Q1 EPS by 9c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Exact Sciences (EXAS) PT Raised to $35 at Jefferies
April 28, 2017 10:40 AM EDTJefferies raised its price target on Exact Sciences (NASDAQ: EXAS) to $35.00 (from $25.00) while maintaining a Buy rating. Test volumes surged to ~100K units compared to Jefferies' ~88K expectations, reflecting a sharp acceleration from its run-rate over the past year.
EXAS raised its 2017... More
Exact Sciences (EXAS) PT Raised to $40 at Cowen; Guides Still Looks 'Very Conservative'
April 27, 2017 3:35 PM EDTCowen raised its price target on Exact Sciences (NASDAQ: EXAS) to $40.00 (from $30.00) while maintaining a Outperform rating following a solid start to the year.
Analyst Doug Schenkel noted revenue, new practice additions, and total orders were well ahead of expectations. In... More
